Compounds and methods for treatment of HCV

Details for Australian Patent Application No. 2007313250 (hide)

International Classifications

Event Publications

21 May 2009 PCT application entered the National Phase

PCT publication WO2008/048589 Priority application(s): WO2008/048589

15 October 2009 Amendment Made

The nature of the amendment is: Amend the name of the inventors add co-inventor Liu, Yixin and correct co-inventor from Wobbe, C. Richard to Wobbe, Richard C.

10 December 2009 Amendment Made

The nature of the amendment is: Amend the name of the co-inventor from Ruoqiu, Wu to Wu, Ruoqiu

10 December 2009 Corrigenda

Amendments - Amendments Made Under the name XTL Biopharmaceuticals Ltd, Application No. 2007313250, under INID (72) correct the co-inventor name to Wobbe, C. Richard Corrigenda

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.